相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells
Hemant K. Mishra et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
A head-to-tail view of L-selectin and its impact on neutrophil behaviour
Aleksandar Ivetic
CELL AND TISSUE RESEARCH (2018)
Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells
Katja Srpan et al.
JOURNAL OF CELL BIOLOGY (2018)
Single Degranulations in NK Cells Can Mediate Target Cell Killing
Lavesh A. Gwalani et al.
JOURNAL OF IMMUNOLOGY (2018)
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
Rohtesh S. Mehta et al.
FRONTIERS IN IMMUNOLOGY (2018)
The emerging role of ADAM metalloproteinases in immunity
Bart N. Lambrecht et al.
NATURE REVIEWS IMMUNOLOGY (2018)
IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer
M. Felices et al.
GYNECOLOGIC ONCOLOGY (2017)
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17
Petra C. Buchanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
Marcia L. Moss et al.
MEDIATORS OF INFLAMMATION (2017)
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
Thomas Kammertoens et al.
NATURE (2017)
Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
Joseph Dosch et al.
ONCOTARGET (2017)
Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis
Hemant K. Mishra et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Generation of Off-the-Shelf Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
Jieming Zeng et al.
STEM CELL REPORTS (2017)
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Sourav Paul et al.
FRONTIERS IN IMMUNOLOGY (2017)
Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions
Simone Battella et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer
Reba Mustafi et al.
CLINICAL CANCER RESEARCH (2016)
NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing
Hsiang-Ting Hsu et al.
JOURNAL OF CELL BIOLOGY (2016)
Molecular basis for the mechanism of action of an anti-TACE antibody
Li Peng et al.
MABS (2016)
The role of ADAM17 in tumorigenesis and progression of breast cancer
Hongyu Shen et al.
TUMOR BIOLOGY (2016)
ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview
Soichi Takeda
TOXINS (2016)
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
Nives Giebeler et al.
TOXINS (2016)
Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
F. Caiazza et al.
BRITISH JOURNAL OF CANCER (2015)
Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
Markus Granzin et al.
CYTOTHERAPY (2015)
A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways
Jonathan Rios-Doria et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Cytokine secretion and NK cell activity in human ADAM17 deficiency
Pinchas Tsukerman et al.
ONCOTARGET (2015)
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wei Wang et al.
FRONTIERS IN IMMUNOLOGY (2015)
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients
M. Christina Cox et al.
ONCOIMMUNOLOGY (2015)
Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells
Yawu Jing et al.
PLOS ONE (2015)
ADAM17-Mediated Shedding of FcγRIIIA on Human NK Cells: Identification of the Cleavage Site and Relationship with Activation
Laurie Lajoie et al.
JOURNAL OF IMMUNOLOGY (2014)
Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy
Hang Fai Kwok et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Fcγ Receptor IIIa Single-Nucleotide Polymorphisms and Haplotypes Affect Human IgG Binding and Are Associated With Lupus Nephritis in African Americans
Chaoling Dong et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils
Yue Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
Rizwan Romee et al.
BLOOD (2013)
Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy
Q. Zhou et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17
Guranda Chitadze et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Activity of ADAM17 (a Disintegrin and Metalloprotease 17) Is Regulated by Its Noncatalytic Domains and Secondary Structure of its Substrates
Roma Stawikowska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Membrane-Type 6 Matrix Metalloproteinase Regulates the Activation-Induced Downmodulation of CD16 in Human Primary NK Cells
Giovanna Peruzzi et al.
JOURNAL OF IMMUNOLOGY (2013)
Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry
Amir Horowitz et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies
Ursula J. E. Seidel et al.
FRONTIERS IN IMMUNOLOGY (2013)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
Antibody-Dependent Cell-Mediated Cytotoxicity Overcomes NK Cell Resistance in MLL-Rearranged Leukemia Expressing Inhibitory KIR Ligands but Not Activating Ligands
Wing Keung Chan et al.
CLINICAL CANCER RESEARCH (2012)
L-Selectin - A dynamic regulator of leukocyte migration
Stefanie Wedepohl et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity
Jennifer T. Grier et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1
Ruipeng Wang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment
Chunmei Long et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
Frances M. Richards et al.
PLOS ONE (2012)
Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism
Suresh Veeramani et al.
BLOOD (2011)
Different Signaling Pathways Stimulate a Disintegrin and Metalloprotease-17 (ADAM17) in Neutrophils during Apoptosis and Activation
Yue Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inflammatory Skin and Bowel Disease Linked to ADAM17 Deletion
Diana C. Blaydon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cross-domain inhibition of TACE ectodomain
Christopher J. Tape et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
Athena Chalaris et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
Yenan T. Bryceson et al.
BLOOD (2009)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
Cutting Edge: The Metalloproteinase ADAM17/TNF-α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
Philippe Boutet et al.
JOURNAL OF IMMUNOLOGY (2009)
Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection
Qingquan Liu et al.
JOURNAL OF VIROLOGY (2009)
Tumor-associated MICA is shed by ADAM proteases
Inja Waldhauer et al.
CANCER RESEARCH (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphism
Evdoxia Hatjiharissi et al.
BLOOD (2007)
CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases
B. Grzywacz et al.
LEUKEMIA (2007)
ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding
Ying Li et al.
BLOOD (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-α-converting enzyme (TACE)/ADAM-17
S Fabre-Lafay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The roles of IFNγ in protection against tumor development and cancer immunoediting
H Ikeda et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Different proteolytic mechanisms involved in FcγRIIIb shedding from human neutrophils
PJ Middelhoven et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
L-selectin shedding regulates leukocyte recruitment
A Hafezi-Moghadam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Effects of selective protein kinase C inhibitors on the proteolytic down-regulation of L-selectin from chemoattractant-activated neutrophils
SR Alexander et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
分享论文
